Evidence map›Paper›PMID 32545320›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis and Antibacterial Analysis of Analogues of the Marine Alkaloid Pseudoceratidine.

David Barker, Stephanie Lee, Kyriakos G Varnava, Kevin Sparrow, Michelle van Rensburg, Rebecca C Deed, Melissa M Cadelis, Steven A Li, Brent R Copp, Vijayalekshmi Sarojini and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David BarkerSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-3425-6552
Stephanie LeeSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.
Kyriakos G VarnavaSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.
Kevin SparrowSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.
Michelle van RensburgSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.
Rebecca C DeedSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0001-6121-6786
Melissa M CadelisSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0003-3883-0109
Steven A LiSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0001-6029-1274
Brent R CoppSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0001-5492-5269
Vijayalekshmi SarojiniSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.
Lisa I PilkingtonSchool of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-9292-3261

Funding

Lottery Health Research Postdoctoral Fellowship 2017MacDiarmid Institute for Advanced Materials and Nanotechnology MD Comm Fund 2019
6 · The paper itself

Abstract

In an effort to gain more understanding on the structure activity relationship of pseudoceratidine

Indexed as

AlkaloidsAnimalsAnti-Bacterial AgentsBiological ProductsGram-Negative BacteriaGram-Positive BacteriaHalogenationMicrobial Sensitivity TestsMolecular StructurePoriferaStructure-Activity RelationshipAlkaloidsAnti-Bacterial AgentsBiological Productsanalogue synthesisantibacterial activitymarine natural productpseudoceratidineSAR

Identifiers

PMID32545320
PMCPMC7321382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.